Crinetics Pharmaceuticals (CRNX) Other Gross PP&E Adjustments: 2017-2025
Historic Other Gross PP&E Adjustments for Crinetics Pharmaceuticals (CRNX) over the last 8 years, with Sep 2025 value amounting to -$19.7 million.
- Crinetics Pharmaceuticals' Other Gross PP&E Adjustments rose 22.87% to -$19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.6 million, marking a year-over-year increase of 18.43%. This contributed to the annual value of -$41.8 million for FY2024, which is 2.36% up from last year.
- As of Q3 2025, Crinetics Pharmaceuticals' Other Gross PP&E Adjustments stood at -$19.7 million, which was down 11.79% from -$17.6 million recorded in Q2 2025.
- Crinetics Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $6.6 million during Q2 2023, with a 5-year trough of -$42.8 million in Q4 2023.
- Over the past 3 years, Crinetics Pharmaceuticals' median Other Gross PP&E Adjustments value was -$25.6 million (recorded in 2024), while the average stood at -$22.2 million.
- Per our database at Business Quant, Crinetics Pharmaceuticals' Other Gross PP&E Adjustments surged by 360.51% in 2022 and then tumbled by 1,967.97% in 2023.
- Quarterly analysis of 5 years shows Crinetics Pharmaceuticals' Other Gross PP&E Adjustments stood at -$1.5 million in 2021, then slumped by 39.30% to -$2.1 million in 2022, then tumbled by 1,967.97% to -$42.8 million in 2023, then increased by 2.36% to -$41.8 million in 2024, then increased by 22.87% to -$19.7 million in 2025.
- Its Other Gross PP&E Adjustments was -$19.7 million in Q3 2025, compared to -$17.6 million in Q2 2025 and -$21.4 million in Q1 2025.